BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25940622)

  • 1. The SOX9 upstream region prone to chromosomal aberrations causing campomelic dysplasia contains multiple cartilage enhancers.
    Yao B; Wang Q; Liu CF; Bhattaram P; Li W; Mead TJ; Crish JF; Lefebvre V
    Nucleic Acids Res; 2015 Jun; 43(11):5394-408. PubMed ID: 25940622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway.
    Lefebvre V; Behringer RR; de Crombrugghe B
    Osteoarthritis Cartilage; 2001; 9 Suppl A():S69-75. PubMed ID: 11680692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through super-enhancers to drive chondrogenesis.
    Liu CF; Lefebvre V
    Nucleic Acids Res; 2015 Sep; 43(17):8183-203. PubMed ID: 26150426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hmgb1 can facilitate activation of the matrilin-1 gene promoter by Sox9 and L-Sox5/Sox6 in early steps of chondrogenesis.
    Szénási T; Kénesi E; Nagy A; Molnár A; Bálint BL; Zvara Á; Csabai Z; Deák F; Boros Oláh B; Mátés L; Nagy L; Puskás LG; Kiss I
    Biochim Biophys Acta; 2013 Oct; 1829(10):1075-91. PubMed ID: 23860260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer.
    Han Y; Lefebvre V
    Mol Cell Biol; 2008 Aug; 28(16):4999-5013. PubMed ID: 18559420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial CRISPR/Cas9 Approach to Elucidate a Far-Upstream Enhancer Complex for Tissue-Specific Sox9 Expression.
    Mochizuki Y; Chiba T; Kataoka K; Yamashita S; Sato T; Kato T; Takahashi K; Miyamoto T; Kitazawa M; Hatta T; Natsume T; Takai S; Asahara H
    Dev Cell; 2018 Sep; 46(6):794-806.e6. PubMed ID: 30146478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionarily conserved, growth plate zone-specific regulation of the matrilin-1 promoter: L-Sox5/Sox6 and Nfi factors bound near TATA finely tune activation by Sox9.
    Nagy A; Kénesi E; Rentsendorj O; Molnár A; Szénási T; Sinkó I; Zvara A; Oommen ST; Barta E; Puskás LG; Lefebvre V; Kiss I
    Mol Cell Biol; 2011 Feb; 31(4):686-99. PubMed ID: 21173167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous SOX9 mutations allowing for residual DNA-binding and transcriptional activation lead to the acampomelic variant of campomelic dysplasia.
    Staffler A; Hammel M; Wahlbuhl M; Bidlingmaier C; Flemmer AW; Pagel P; Nicolai T; Wegner M; Holzinger A
    Hum Mutat; 2010 Jun; 31(6):E1436-44. PubMed ID: 20513132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical impact of chromosomal rearrangements with breakpoints upstream of the SOX9 gene: two novel de novo balanced translocations associated with acampomelic campomelic dysplasia.
    Fonseca AC; Bonaldi A; Bertola DR; Kim CA; Otto PA; Vianna-Morgante AM
    BMC Med Genet; 2013 May; 14():50. PubMed ID: 23648064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX9 and the many facets of its regulation in the chondrocyte lineage.
    Lefebvre V; Dvir-Ginzberg M
    Connect Tissue Res; 2017 Jan; 58(1):2-14. PubMed ID: 27128146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly conserved proximal promoter element harbouring paired Sox9-binding sites contributes to the tissue- and developmental stage-specific activity of the matrilin-1 gene.
    Rentsendorj O; Nagy A; Sinkó I; Daraba A; Barta E; Kiss I
    Biochem J; 2005 Aug; 389(Pt 3):705-16. PubMed ID: 15804237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant-negative SOX9 mutations in campomelic dysplasia.
    Csukasi F; Duran I; Zhang W; Martin JH; Barad M; Bamshad M; Weis MA; Eyre D; Krakow D; Cohn DH
    Hum Mutat; 2019 Dec; 40(12):2344-2352. PubMed ID: 31389106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Sox5 and Sox6 proteins enhance chondrogenic miR-140 microRNA expression by strengthening dimeric Sox9 activity.
    Yamashita S; Miyaki S; Kato Y; Yokoyama S; Sato T; Barrionuevo F; Akiyama H; Scherer G; Takada S; Asahara H
    J Biol Chem; 2012 Jun; 287(26):22206-15. PubMed ID: 22547066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoderm-specific Stat3 deletion affects expression of Sox9 yielding Sox9-dependent phenotypes.
    Hall MD; Murray CA; Valdez MJ; Perantoni AO
    PLoS Genet; 2017 Feb; 13(2):e1006610. PubMed ID: 28166224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.
    Akiyama H; Chaboissier MC; Martin JF; Schedl A; de Crombrugghe B
    Genes Dev; 2002 Nov; 16(21):2813-28. PubMed ID: 12414734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional mechanisms of chondrocyte differentiation.
    de Crombrugghe B; Lefebvre V; Behringer RR; Bi W; Murakami S; Huang W
    Matrix Biol; 2000 Sep; 19(5):389-94. PubMed ID: 10980415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel craniofacial regulatory domains located far upstream of SOX9 and disrupted in Pierre Robin sequence.
    Gordon CT; Attanasio C; Bhatia S; Benko S; Ansari M; Tan TY; Munnich A; Pennacchio LA; Abadie V; Temple IK; Goldenberg A; van Heyningen V; Amiel J; FitzPatrick D; Kleinjan DA; Visel A; Lyonnet S
    Hum Mutat; 2014 Aug; 35(8):1011-20. PubMed ID: 24934569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5.
    Hattori T; Coustry F; Stephens S; Eberspaecher H; Takigawa M; Yasuda H; de Crombrugghe B
    Nucleic Acids Res; 2008 May; 36(9):3011-24. PubMed ID: 18390577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial joint morphogenesis requires the chondrogenic action of Sox5 and Sox6 in growth plate and articular cartilage.
    Dy P; Smits P; Silvester A; Penzo-Méndez A; Dumitriu B; Han Y; de la Motte CA; Kingsley DM; Lefebvre V
    Dev Biol; 2010 May; 341(2):346-59. PubMed ID: 20206616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocation and deletion around SOX9 in a patient with acampomelic campomelic dysplasia and sex reversal.
    Jakubiczka S; Schröder C; Ullmann R; Volleth M; Ledig S; Gilberg E; Kroisel P; Wieacker P
    Sex Dev; 2010; 4(3):143-9. PubMed ID: 20453475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.